Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. (Articolo in rivista)

Type
Label
  • Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. (Articolo in rivista) (literal)
Anno
  • 2013-01-01T00:00:00+01:00 (literal)
Alternative label
  • Lanzillo R, Bonavita S, Quarantelli M, Vacca G, Lus G, Amato L, Carotenuto A, Tedeschi G, Orefice G, Brescia Morra V (2013)
    Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
    in Neurological sciences (Testo stamp.)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Lanzillo R, Bonavita S, Quarantelli M, Vacca G, Lus G, Amato L, Carotenuto A, Tedeschi G, Orefice G, Brescia Morra V (literal)
Pagina inizio
  • 521 (literal)
Pagina fine
  • 528 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 34 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 4 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Neurological Sciences Department, Federico II University, Via Pansini 5, 80131 Naples, Italy Hermitage Capodimonte IDC, Naples, Italy Department of Neurological Sciences, Second University of Naples, Naples, Italy Diagnostic Imaging Department, Federico II University, Naples, Italy Biostructure and Bioimaging Institute, National Research Council, Naples, Italy (literal)
Titolo
  • Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it